EphA2 promotes tumorigenicity of cervical cancer by up-regulating CDK6.

This study demonstrates the oncogenic activity of EphA2 in vitro and in vivo, which provides insights into the relevant mechanisms that might lead to novel treatments for CC.
PMID: 33586348 [PubMed - as supplied by publisher]

Source: J Cell Mol Med - February 14, 2021 Category: Molecular Biology Authors: Huang C, Chen Z, He Y, He Z, Ban Z, Zhu Y, Ding L, Yang C, Jeong JH, Yuan W, Yang L Tags: J Cell Mol Med Source Type: research